Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Heranba Industries Ltd (HERANBA) is currently trading at 144.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Heranba Industries Limited is an integrated Indian agrochemical manufacturer producing synthetic pyrethroids, intermediates and a broad range of formulations, operating three manufacturing units in Gujarat with in‑house R&D and an aggregate capacity of 14,024 MTPA, exporting to international markets from Vapi and the recently commissioned Saykha and Sarigam units. FY2026 standalone revenue rose to Rs.1,755.6 crore (≈17% YoY) while consolidated revenue reached Rs.1,595.0 crore (≈13% YoY); however the consolidated business swung to a net loss of Rs.77.6 crore due to higher depreciation, finance cost and working capital pressures, creating a notable divergence between standalone profitability and consolidated results. Liquidity and working capital deteriorated materially in FY2026: trade receivables and inventories increased significantly (standalone receivables Rs.649.9 crore, inventories Rs.299.4 crore), cash fell to Rs.11.6 crore and short‑term borrowings rose to Rs.458.1 crore, while large intra‑group loans and repayments influenced investing cashflows and overall liquidity. Strategically, the company accelerated capacity and capability building by commissioning Saykha and Sarigam phases in 2025 (adding ~9,000 MTPA) and acquiring Daikaffil to secure a Tarapur R&D centre; the Board approved audited results with an unmodified opinion and did not recommend a dividend for FY2026 to conserve funds for expansion and integration.
Over the past 52 weeks, Heranba Industries Ltd has traded between a low of ₹144.50 and a high of ₹305.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Heranba Industries Ltd has a market capitalization of approximately 593.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Heranba Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -7.73 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 593.80 Cr, Heranba Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Heranba Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Heranba Industries Ltd is -7.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The stock rose after the company reported improved profitability in Q1 FY27 and a return to profit from a large loss in Q4 FY26.
Heranba Industries reported a consolidated net profit of ₹7.03 crore for the quarter ended June 30, 2026 (Q1FY27).
Heranba Industries Limited is an integrated Indian agrochemical manufacturer producing synthetic pyrethroids, intermediates and a broad range of formulations, operating three manufacturing units in Gujarat with in‑house R&D and an aggregate capacity of 14,024 MTPA, exporting to international markets from Vapi and the recently commissioned Saykha and Sarigam units.
FY2026 standalone revenue rose to Rs.1,755.6 crore (≈17% YoY) while consolidated revenue reached Rs.1,595.0 crore (≈13% YoY); however the consolidated business swung to a net loss of Rs.77.6 crore due to higher depreciation, finance cost and working capital pressures, creating a notable divergence between standalone profitability and consolidated results.
Liquidity and working capital deteriorated materially in FY2026: trade receivables and inventories increased significantly (standalone receivables Rs.649.9 crore, inventories Rs.299.4 crore), cash fell to Rs.11.6 crore and short‑term borrowings rose to Rs.458.1 crore, while large intra‑group loans and repayments influenced investing cashflows and overall liquidity.
Strategically, the company accelerated capacity and capability building by commissioning Saykha and Sarigam phases in 2025 (adding ~9,000 MTPA) and acquiring Daikaffil to secure a Tarapur R&D centre; the Board approved audited results with an unmodified opinion and did not recommend a dividend for FY2026 to conserve funds for expansion and integration.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
594 Cr
High Risk
-7.7
18.4
—
0.8
305.00
144.50
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
125.00 | 848 Cr | 17.35 | 2.89 | 0.00 | — | — | 0.00 | ||
144.80 | 594 Cr | -7.73 | 0.78 | 0.00 | -10.03 | -1.57 | -3.90 | ||
13.91 | 525 Cr | 17.73 | 0.77 | 0.68 | 1.15 | 5.22 | 1.76 | ||
298.75 | 501 Cr | 25.50 | 0.83 | 0.16 | 2.03 | 4.36 | 2.40 | ||
183.24 | 463 Cr | 13.00 | 1.20 | 0.00 | 8.23 | 13.07 | 8.21 | ||
176.80 | 400 Cr | 24.23 | 3.28 | 0.00 | 13.55 | 15.05 | 5.32 | ||
61.00 | 370 Cr | 9.59 | 0.81 | 0.00 | 8.71 | 10.76 | 4.68 | ||
| Median: 7 Co. | — | 144.80 | 501 Cr | 17.35 | 0.83 | 0.00 | 5.13 | 7.99 | 2.40 |
